{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:04:08Z","timestamp":1791975848798,"version":"4.4.0"},"reference-count":52,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,1]]},"abstract":"<jats:p>OBJECTIVE. Folic acid fortification has reduced neural tube defect prevalence by 50% to 70%. It is unlikely that fortification levels will be increased to reduce neural tube defect prevalence further. Therefore, it is important to identify other modifiable risk factors. Vitamin B12 is metabolically related to folate; moreover, previous studies have found low B12 status in mothers of children affected by neural tube defect. Our objective was to quantify the effect of low B12 status on neural tube defect risk in a high-prevalence, unfortified population.<\/jats:p>\n               <jats:p>METHODS. We assessed pregnancy vitamin B12 status concentrations in blood samples taken at an average of 15 weeks\u2019 gestation from 3 independent nested case-control groups of Irish women within population-based cohorts, at a time when vitamin supplementation or food fortification was rare. Group 1 blood samples were from 95 women during a neural tube defect\u2013affected pregnancy and 265 control subjects. Group 2 included blood samples from 107 women who had a previous neural tube defect birth but whose current pregnancy was not affected and 414 control subjects. Group 3 samples were from 76 women during an affected pregnancy and 222 control subjects.<\/jats:p>\n               <jats:p>RESULTS. Mothers of children affected by neural tube defect had significantly lower B12 status. In all 3 groups those in the lowest B12 quartiles, compared with the highest, had between two and threefold higher adjusted odds ratios for being the mother of a child affected by neural tube defect. Pregnancy blood B12 concentrations of &amp;lt;250 ng\/L were associated with the highest risks.<\/jats:p>\n               <jats:p>CONCLUSIONS. Deficient or inadequate maternal vitamin B12 status is associated with a significantly increased risk for neural tube defects. We suggest that women have vitamin B12 levels of &amp;gt;300 ng\/L (221 pmol\/L) before becoming pregnant. Improving B12 status beyond this level may afford a further reduction in risk, but this is uncertain.<\/jats:p>","DOI":"10.1542\/peds.2008-1173","type":"journal-article","created":{"date-parts":[[2009,3,2]],"date-time":"2009-03-02T12:49:02Z","timestamp":1235998142000},"page":"917-923","source":"Crossref","is-referenced-by-count":248,"title":["Maternal Vitamin B12 Status and Risk of Neural Tube Defects in a Population With High Neural Tube Defect Prevalence and No Folic Acid Fortification"],"prefix":"10.1542","volume":"123","author":[{"given":"Anne M.","family":"Molloy","sequence":"first","affiliation":[{"name":"Schools of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peadar N.","family":"Kirke","sequence":"additional","affiliation":[{"name":"Child Health Epidemiology Unit, Health Research Board, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Troendle","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Statistics, and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Burke","sequence":"additional","affiliation":[{"name":"Child Health Epidemiology Unit, Health Research Board, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Sutton","sequence":"additional","affiliation":[{"name":"Child Health Epidemiology Unit, Health Research Board, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence C.","family":"Brody","sequence":"additional","affiliation":[{"name":"Molecular Pathogenesis Section, Genome Technology Branch, National Human Genome Research Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Scott","sequence":"additional","affiliation":[{"name":"Immunology and Biochemistry and Immunology, Trinity College, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Mills","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Statistics, and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2009,3,1]]},"reference":[{"key":"2021120902483975600_R1","doi-asserted-by":"crossref","unstructured":"MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet.\u20081991;338(8760):131\u2013137","DOI":"10.1016\/0140-6736(91)90133-A"},{"key":"2021120902483975600_R2","doi-asserted-by":"crossref","unstructured":"Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med.\u20081992;327(26):1832\u20131835","DOI":"10.1056\/NEJM199212243272602"},{"key":"2021120902483975600_R3","doi-asserted-by":"crossref","unstructured":"Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China: China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med.\u20081999;341(20):1485\u20131490","DOI":"10.1056\/NEJM199911113412001"},{"key":"2021120902483975600_R4","doi-asserted-by":"crossref","unstructured":"Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA.\u20082001;285(23):2981\u20132986","DOI":"10.1001\/jama.285.23.2981"},{"key":"2021120902483975600_R5","doi-asserted-by":"crossref","unstructured":"Mills JL, Signore C. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol.\u20082004;70(11):844\u2013845","DOI":"10.1002\/bdra.20075"},{"key":"2021120902483975600_R6","doi-asserted-by":"crossref","unstructured":"Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet.\u20082002;360(9350):2047\u20132048","DOI":"10.1016\/S0140-6736(02)11994-5"},{"key":"2021120902483975600_R7","unstructured":"Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ.\u20082002;167(3):241\u2013245"},{"key":"2021120902483975600_R8","doi-asserted-by":"crossref","unstructured":"Liu S, West R, Randell E, et al. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth.\u20082004;4(1):20","DOI":"10.1186\/1471-2393-4-20"},{"key":"2021120902483975600_R9","doi-asserted-by":"crossref","unstructured":"Lopez-Camelo JS, Orioli IM, da Graca Dutra M, et al. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A.\u20082005;135(2):120\u2013125","DOI":"10.1002\/ajmg.a.30651"},{"key":"2021120902483975600_R10","doi-asserted-by":"crossref","unstructured":"Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race\/ethnicity: 1995\u20132002. Pediatrics.\u20082005;116(3):580\u2013586","DOI":"10.1542\/peds.2005-0592"},{"key":"2021120902483975600_R11","doi-asserted-by":"crossref","unstructured":"Brent RL, Oakley GP Jr, Mattison DR. The unnecessary epidemic of folic acid-preventable spina bifida and anencephaly. Pediatrics.\u20082000;106(4):825\u2013827","DOI":"10.1542\/peds.106.4.825"},{"key":"2021120902483975600_R12","doi-asserted-by":"crossref","unstructured":"Brent RL, Oakley GP Jr. Triumph and\/or tragedy: the present Food and Drug Administration program of enriching grains with folic acid. Pediatrics.\u20082006;117(3):930\u2013932","DOI":"10.1542\/peds.2005-2557"},{"key":"2021120902483975600_R13","doi-asserted-by":"crossref","unstructured":"Brent RL, Oakley GP Jr. The Food and Drug Administration must require the addition of more folic acid in \u201cenriched\u201d flour and other grains. Pediatrics.\u20082005;116(3):753\u2013755","DOI":"10.1542\/peds.2005-1536"},{"key":"2021120902483975600_R14","doi-asserted-by":"crossref","unstructured":"Werler MM, Louik C, Shapiro S, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA.\u20081996;275(14):1089\u20131092","DOI":"10.1001\/jama.275.14.1089"},{"key":"2021120902483975600_R15","doi-asserted-by":"crossref","unstructured":"Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics.\u20082003;111(5 pt 2):1152\u20131158","DOI":"10.1542\/peds.111.S1.1152"},{"key":"2021120902483975600_R16","doi-asserted-by":"crossref","unstructured":"Waller DK, Mills JL, Simpson JL, et al. Are obese women at higher risk for producing malformed offspring?Am J Obstet Gynecol.\u20081994;170(2):541\u2013548","DOI":"10.1016\/S0002-9378(94)70224-1"},{"key":"2021120902483975600_R17","doi-asserted-by":"crossref","unstructured":"Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet.\u20081995;345(8943):149\u2013151","DOI":"10.1016\/S0140-6736(95)90165-5"},{"key":"2021120902483975600_R18","doi-asserted-by":"crossref","unstructured":"Steegers-Theunissen RP, Boers GH, Trijbels FJ, Eskes TK. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med.\u20081991;324(3):199\u2013200","DOI":"10.1056\/NEJM199101173240315"},{"key":"2021120902483975600_R19","doi-asserted-by":"crossref","unstructured":"Schorah CJ, Smithells RW, Scott J. Vitamin B12 and anencephaly. Lancet.\u20081980;1(8173):880","DOI":"10.1016\/S0140-6736(80)91381-1"},{"key":"2021120902483975600_R20","unstructured":"Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med.\u20081993;86(11):703\u2013708"},{"key":"2021120902483975600_R21","unstructured":"Hao L, Liu M, Liu X, Chen X, Tang Y, Li Z. Relationship between folate, vitamin B12, total plasma homocysteine and mutation of reductase [in Chinese]. Zhonghua Yu Fang Yi Xue Za Zhi.\u20082000;34(1):22\u201324"},{"key":"2021120902483975600_R22","doi-asserted-by":"crossref","unstructured":"Ray JG, Wyatt PR, Thompson MD, et al. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology.\u20082007;18(3):362\u2013366","DOI":"10.1097\/01.ede.0000257063.77411.e9"},{"key":"2021120902483975600_R23","unstructured":"Gaber KR, Farag MK, Soliman SE, El-Bassyouni HT, El-Kamah G. Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients. Clin Lab.\u20082007;53(1\u20132):69\u201375"},{"key":"2021120902483975600_R24","doi-asserted-by":"crossref","unstructured":"Zhang T, Xin R, Gu X, et al. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr.\u20082008; In press","DOI":"10.1017\/S1368980008002735"},{"key":"2021120902483975600_R25","doi-asserted-by":"crossref","unstructured":"Wright ME. A case-control study of maternal nutrition and neural tube defects in Northern Ireland. Midwifery.\u20081995;11(3):146\u2013152","DOI":"10.1016\/0266-6138(95)90029-2"},{"key":"2021120902483975600_R26","doi-asserted-by":"crossref","unstructured":"Suarez L, Hendricks K, Felkner M, Gunter E. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol.\u20082003;13(2):81\u201388","DOI":"10.1016\/S1047-2797(02)00267-3"},{"key":"2021120902483975600_R27","doi-asserted-by":"crossref","unstructured":"Groenen PM, van Rooij IA, Peer PG, Gooskens RH, Zielhuis GA, Steegers-Theunissen RP. Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. Am J Obstet Gynecol.\u20082004;191(1):11\u201317","DOI":"10.1016\/j.ajog.2003.12.032"},{"key":"2021120902483975600_R28","doi-asserted-by":"crossref","unstructured":"Gardiki-Kouidou P, Seller MJ. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects. Clin Genet.\u20081988;33(6):441\u2013448","DOI":"10.1111\/j.1399-0004.1988.tb03478.x"},{"key":"2021120902483975600_R29","doi-asserted-by":"crossref","unstructured":"Dawson EB, Evans DR, Van Hook JW. Amniotic fluid B12 and folate levels associated with neural tube defects. Am J Perinatol.\u20081998;15(9):511\u2013514","DOI":"10.1055\/s-2007-993975"},{"key":"2021120902483975600_R30","doi-asserted-by":"crossref","unstructured":"Economides DL, Ferguson J, Mackenzie IZ, Darley J, Ware II, Holmes-Siedle M. Folate and vitamin B12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects. Br J Obstet Gynaecol.\u20081992;99(1):23\u201325","DOI":"10.1111\/j.1471-0528.1992.tb14386.x"},{"key":"2021120902483975600_R31","doi-asserted-by":"crossref","unstructured":"Steen MT, Boddie AM, Fisher AJ, et al. Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid. Prenat Diagn.\u20081998;18(6):545\u2013555","DOI":"10.1002\/(SICI)1097-0223(199806)18:6<545::AID-PD293>3.0.CO;2-2"},{"key":"2021120902483975600_R32","doi-asserted-by":"crossref","unstructured":"Weekes EW, Tamura T, Davis RO, et al. Nutrient levels in amniotic fluid from women with normal and neural tube defect pregnancies. Biol Neonate.\u20081992;61(4):226\u2013231","DOI":"10.1159\/000243747"},{"key":"2021120902483975600_R33","doi-asserted-by":"crossref","unstructured":"Murphy JF. Drugs and pregnancy. Ir Med J.\u20081984;77(2):52\u201356","DOI":"10.1007\/978-94-011-7618-7_5"},{"key":"2021120902483975600_R34","doi-asserted-by":"crossref","unstructured":"Molloy AM, Kirke P, Hillary I, Weir DG, Scott JM. Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects. Arch Dis Child.\u20081985;60(7):660\u2013665","DOI":"10.1136\/adc.60.7.660"},{"key":"2021120902483975600_R35","doi-asserted-by":"crossref","unstructured":"Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA.\u20081995;274(21):1698\u20131702","DOI":"10.1001\/jama.274.21.1698"},{"key":"2021120902483975600_R36","doi-asserted-by":"crossref","unstructured":"Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol.\u20082001;185(4):781\u2013785","DOI":"10.1067\/mob.2001.117304"},{"key":"2021120902483975600_R37","doi-asserted-by":"crossref","unstructured":"Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampsia. Am J Obstet Gynecol.\u20082003;189(2):391\u2013394","DOI":"10.1067\/S0002-9378(03)00669-0"},{"key":"2021120902483975600_R38","unstructured":"Eastern Regional Health Authority. Congenital Anomalies in the Eastern Region of Ireland 1980\u20131999. Report of the Dublin EUROCAT Registry on Twenty Years of Congenital Anomaly Surveillance. Dublin, Ireland: Eastern Regional Health Authority; 2001"},{"key":"2021120902483975600_R39","doi-asserted-by":"crossref","unstructured":"Kirke PN, Daly LE, Elwood JH. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis Child.\u20081992;67(12):1442\u20131446","DOI":"10.1136\/adc.67.12.1442"},{"key":"2021120902483975600_R40","doi-asserted-by":"crossref","unstructured":"Murphy MM, Molloy AM, Ueland PM, et al. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J Nutr.\u20082007;137(8):1863\u20131867","DOI":"10.1093\/jn\/137.8.1863"},{"key":"2021120902483975600_R41","doi-asserted-by":"crossref","unstructured":"Milman N, Byg KE, Bergholt T, Eriksen L, Hvas AM. Cobalamin status during normal pregnancy and postpartum: a longitudinal study comprising 406 Danish women. Eur J Haematol.\u20082006;76(6):521\u2013525","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2550.x"},{"key":"2021120902483975600_R42","doi-asserted-by":"crossref","unstructured":"Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA.\u20082007;297(21):2351\u20132359","DOI":"10.1001\/jama.297.21.2351"},{"key":"2021120902483975600_R43","doi-asserted-by":"crossref","unstructured":"Morris MC, Evans DA, Bienias JL, et al. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol.\u20082005;62(4):641\u2013645","DOI":"10.1001\/archneur.62.4.641"},{"key":"2021120902483975600_R44","doi-asserted-by":"crossref","unstructured":"Troen AM, Mitchell B, Sorensen B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr.\u20082006;136(1):189\u2013194","DOI":"10.1093\/jn\/136.1.189"},{"key":"2021120902483975600_R45","doi-asserted-by":"crossref","unstructured":"Herbert V, Bigaouette J. Call for endorsement of a petition to the Food and Drug Administration to always add vitamin B-12 to any folate fortification or supplement. Am J Clin Nutr.\u20081997;65(2):572\u2013573","DOI":"10.1093\/ajcn\/65.2.572"},{"key":"2021120902483975600_R46","doi-asserted-by":"crossref","unstructured":"Oakley GP Jr. Let's increase folic acid fortification and include vitamin B-12. Am J Clin Nutr.\u20081997;65(6):1889\u20131890","DOI":"10.1093\/ajcn\/65.6.1889"},{"key":"2021120902483975600_R47","doi-asserted-by":"crossref","unstructured":"Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999\u20132000. Am J Clin Nutr.\u20082005;82(2):442\u2013450","DOI":"10.1093\/ajcn\/82.2.442"},{"key":"2021120902483975600_R48","doi-asserted-by":"crossref","unstructured":"Saxena S, Carmel R. Racial differences in vitamin B12 levels in the United States. Am J Clin Pathol.\u20081987;88(1):95\u201397","DOI":"10.1093\/ajcp\/88.1.95"},{"key":"2021120902483975600_R49","doi-asserted-by":"crossref","unstructured":"Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr.\u20082007;86(3):718\u2013727","DOI":"10.1093\/ajcn\/86.3.718"},{"key":"2021120902483975600_R50","unstructured":"Knight EM, Spurlock BG, Edwards CH, et al. Biochemical profile of African American women during three trimesters of pregnancy and at delivery. J Nutr.\u20081994;124(6 suppl):943S\u2013953S"},{"key":"2021120902483975600_R51","doi-asserted-by":"crossref","unstructured":"Ray JG, Blom HJ. Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM.\u20082003;96(4):289\u2013295","DOI":"10.1093\/qjmed\/hcg043"},{"key":"2021120902483975600_R52","doi-asserted-by":"crossref","unstructured":"Mills JL, Tuomilehto J, Yu KF, et al. Maternal vitamin levels during pregnancies producing infants with neural tube defects. J Pediatr.\u20081992;120(6):863\u2013871.","DOI":"10.1016\/S0022-3476(05)81951-1"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/3\/917\/1067956\/zpe00309000917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/3\/917\/1067956\/zpe00309000917.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T15:49:22Z","timestamp":1639064962000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/123\/3\/917\/71691\/Maternal-Vitamin-B12-Status-and-Risk-of-Neural"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,1]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,1]]},"published-print":{"date-parts":[[2009,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-1173","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,1]]}}}